Atherogenesis and vascular calcification in mice expressing the human LPA gene

Pathophysiology

Volumn 11, Issue 2, 2004, Pages 113-120

  Teivainen, Päivi A ^a,b   Eliassen, Knut A ^c   Berg, Kre ^a,b   Torsdalen, Kari ^a,b   Svindland, Aud ^d  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Lp(a); Transgenic mice; Vascular calcification

Indexed keywords

FORMALDEHYDE; GELATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; MESSENGER RNA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; ASCENDING AORTA; ATHEROGENESIS; ATHEROGENIC DIET; BLOOD VESSEL CALCIFICATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN GENOME; ISOLATED HEART; LIPID BLOOD LEVEL; LIVER; MALE; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA ANALYSIS; SEX DIFFERENCE; TRANSGENIC MOUSE;

EID: 4444308445     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2004.06.007     Document Type: Article

References (38)

1. K. Berg, G. Dahlen, and M.H. Frick Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease Clin. Genet. 1974 6
2. A.M. Scanu The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events Curr. Cardiol. Rep. 3 2001 385 390
3. J.W. McLean, J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu, and R.M. Lawn cDNA sequence of human apolipoprotein(a) is homologous to plasminogen Nature 330 1987 132 137
4. M.N. Rahman, V. Petrounevitch, Z. Jia, and M.L. Koschinsky Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding Protein Eng. 14 2001 427 438
5. M.J. Chapman, T. Huby, F. Nigon, and J. Thillet Lipoprotein(a): implication in atherothrombosis Atherosclerosis 110 Suppl. 1994 S69 S75
6. M.A. Hancock, M.B. Boffa, S.M. Marcovina, M.E. Nesheim, and M.L. Koschinsky Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces J. Biol. Chem. 278 2003 23260 23269
7. P. Magnaghi, E. Citterio, N. Malgaretti, F. Acquati, S. Ottolenghi, and R. Taramelli Molecular characterisation of the human apo(a)-plasminogen gene family clustered on the telomeric region of chromosome 6 (6q26-27) Hum. Mol. Genet. 3 1994 437 442
8. R.M. Lawn, N.W. Boonmark, K. Schwartz, G.E. Lindahl, D.P. Wade, C.D. Byrne, K.J. Fong, K. Meer, and L. Patthy The recurring evolution of lipoprotein(a) Insights from cloning of hedgehog apolipoprotein(a) J. Biol. Chem. 270 1995 24004 24009
9. R. Lawn, L. Patthy, G. Pesole, and C. Saccone Apolipoproteins(a): a puzzling evolutionary story J. Mol. E 44 1997 234 236
10. K.A. Frazer, G. Narla, J.L. Zhang, and E.M. Rubin The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice Nat. Genet. 9 1995 424 431
11. J. Fan, M. Araki, L. Wu, M. Challah, H. Shimoyamada, R.M. Lawn, H. Kakuta, H. Shikama, and T. Watanabe Assembly of lipoprotein(a) in transgenic rabbits expressing human apolipoprotein(a) Biochem. Biophys. Res. Commun. 255 1999 639 644
12. D. Rouy, N. Duverger, S.D. Lin, F. Emmanuel, L.M. Houdebine, P. Denefle, C. Viglietta, E. Gong, E.M. Rubin, and S.D. Hughes Apolipoprotein(a) yeast artificial chromosome transgenic rabbits Lipoprotein(a) assembly with human and rabbit apolipoprotein B J. Biol. Chem. 273 1998 1247 1251
13. G. Chiesa, H.H. Hobbs, M.L. Koschinsky, R.M. Lawn, S.D. Maika, and R.E. Hammer Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a) J. Biol. Chem. 267 1992 24369 24374
14. M.J. Callow, L.J. Stoltzfus, R.M. Lawn, and E.M. Rubin Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice Proc. Natl. Acad. Sci. U.S.A. 91 1994 2130 2134
15. A. Svindland, K. Berg, K. Eliassen, R.M. Lawn, S. Djurovic, P. Alestrom, T. Noren, and A. Smith Histopathology of arterial lesions in LPA transgenic mice on cholesterol-enriched chow Atherosclerosis 153 2000 349 354
16. R.M. Lawn, A.D. Pearle, L.L. Kunz, E.M. Rubin, J. Reckless, J.C. Metcalfe, and D.J. Grainger Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice J. Biol. Chem. 271 1996 31367 31371
17. N.W. Boonmark, X.J. Lou, Z.J. Yang, K. Schwartz, J.L. Zhang, E.M. Rubin, and R.M. Lawn Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice J. Clin. Invest. 100 1997 558 564
18. R.M. Lawn, D.P. Wade, R.E. Hammer, G. Chiesa, J.G. Verstuyft, and E.M. Rubin Atherogenesis in transgenic mice expressing human apolipoprotein(a) Nature 360 1992 670 672
19. K. Berg, A. Svindland, A.J. Smith, R.M. Lawn, S. Djurovic, A. Alestrom, P. Alestrom, and K. Eliassen Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet Atherosclerosis 163 2002 99 104
20. T. Huby, V. Afzal, C. Doucet, R.M. Lawn, E.L. Gong, M.J. Chapman, J. Thillet, and E.M. Rubin Regulation of the expression of the apolipoprotein(a) gene: evidence for a regulatory role of the 5′ distal apolipoprotein(a) transcription control region enhancer in yeast artificial chromosome transgenic mice Arterioscler. Thromb. Vasc. Biol. 23 2003 1633 1639
21. F. Acquati, R. Hammer, B. Ercoli, V. Mooser, R. Tao, V. Ronicke, A. Michalich, G. Chiesa, R. Taramelli, H.H. Hobbs, and H.J. Muller Transgenic mice expressing a human apolipoprotein[a] allele J. Lipid Res. 40 1999 994 1006
22. P.A. Teivainen, K.A. Eliassen, E.M. Rubin, S. Djurovic, and K. Berg Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice Lipids Health Dis. 3 2004 8
23. B. Paigen, B.Y. Ishida, J. Verstuyft, R.B. Winters, and D. Albee Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice Arteriosclerosis 10 1990 316 323
24. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
25. F.P. Mancini, D.L. Newland, V. Mooser, J. Murata, S. Marcovina, S.G. Young, R.E. Hammer, D.A. Sanan, and H.H. Hobbs Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice Arterioscler. Thromb. Vasc. Biol. 15 1995 1911 1916
26. R.D. Cohen, L.W. Castellani, J.H. Qiao, B.J. Van Lenten, A.J. Lusis, and K. Reue Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV J. Clin. Invest. 1997 99
27. J.J. Badimon, L. Badimon, and V. Fuster Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit J. Clin. Invest. 85 1990 1234 1241
28. N.E. Miller Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis Am. Heart J. 113 1987 589 597
29. N.E. Miller, A. La Ville, and D. Crook Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit Nature 314 1985 109 111
30. F. Parhami, B. Basseri, J. Hwang, Y. Tintut, and L.L. Demer High-density lipoprotein regulates calcification of vascular cells Circ. Res. 91 2002 570 576
31. H. Sun, H. Unoki, X. Wang, J. Liang, T. Ichikawa, Y. Arai, M. Shiomi, S.M. Marcovina, T. Watanabe, and J. Fan Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a) J. Biol. Chem. 277 2002 47486 47492
32. H.H. Hsu In vitro effect of cholesterol on calcifying activity of vesicles isolated from rabbit aortas Biochim. Biophys. Acta 1638 2003 235 240
33. D.A. Purcell-Huynh, R.V. Farese Jr., D.F. Johnson, L.M. Flynn, V. Pierotti, D.L. Newland, M.F. Linton, D.A. Sanan, and S.G. Young Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet J. Clin. Invest. 95 1995 2246 2257
34. J.C. Cohen, G. Chiesa, and H.H. Hobbs Sequence polymorphisms in the apolipoprotein(a) gene Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels J. Clin. Invest. 91 1993 1630 1636
35. Y.F. Perombelon, A.K. Soutar, and B.L. Knight Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles J. Clin. Invest. 93 1994 1481 1492
36. J.E. Hixson, M.L. Britten, G.S. Manis, and D.L. Rainwater Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons J. Biol. Chem. 264 1989 6013 6016
37. D.P. Wade, B.L. Knight, K. Harders-Spengel, and A.K. Soutar Detection and quantitation of apolipoprotein(a) mRNA in human liver and its relationship with plasma lipoprotein(a) concentration Atherosclerosis 91 1991 63 72
38. S. Yu, J. Derr, T.D. Etherton, and P.M. Kris-Etherton Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic Am. J. Clin. Nutr. 61 1995 1129 1139